Latest Cancer News

3-Year Survival Improved with Taflinar®/Mekinist® Combination in Advanced Melanoma (07-21-2016)
Patients with advanced melanoma who were treated with the combination consisting of Taflinar (dabrafenib) plus Mekinist (trametinib) had a significantly improved survival rate at 3 years compared to those... Continue Reading

Loxo Oncology Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration for LOXO-101 (07-19-2016)
Loxo Oncology, Inc. (LOXO), a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, announced that the U.S. Food and Drug Administration... Continue Reading

FDA Places Hold on a Trial Evaluating Genetically Engineered Immune Cells for Cancer Treatment (07-18-2016)
The United States Food and Drug Administration (FDA) has placed a hold on a clinical trial, referred to as the ROCKET trial, due to side effects of the treatment that may be associated with 3 patient deaths. Chimeric... Continue Reading

More Cancer News

Locations

 
 

The Center At Boca Raton
701 NW 13th St.
2nd Floor
Boca Raton, FL 33486
TEL: (561) 955-6400
FAX: (561) 750-7662

 
 
 

The Center At Delray Beach
6282 Linton Blvd.
Delray Beach, Florida 33484
TEL: (561) 495-8307
FAX: (561) 495-6422

 
 
 
Click here for the Lynn Cancer Institute